Vivo Capital Fund VIII, L.P. is 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX). They have made 5 open-market trades across 3 companies since 2017, most recently 2021-02-09.
CIK 0001618788
3 open-market purchases totalling $19.8M since 2017, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | BUY | 2021-02-09 | 2021-02-09 | $17.00 | $8.1M | -8.5% | +5.5% | -32.5% |
| CRNX | SELL | 2020-04-03 | 2020-04-07 | $13.81 | $4.3M | +20.7% | +28.3% | +30.6% |
| CRNX | SELL | 2020-02-04 | 2020-02-06 | $22.80 | $606K | +3.1% | -13.5% | -12.6% |
| CRNX | BUY | 2018-07-20 | 2018-07-20 | $19.26 | $9.8M | +10.1% | +38.7% | +1.5% |
| BPMX | BUY | 2017-04-28 | 2017-05-01 | $0.78 | $2.0M | -44.2% | -23.2% | -58.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.